Diffuse Diabetic Maculopathy With Intravitreal Triamcinolone or Laser
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
This study compares the use of intravitreous triamcinolone and laser therapy to treat
maculopahty in patients with type 2 diabetes mellitus in a short-tem period of 6 months